Literature DB >> 19520160

Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy.

Amie J Dirks-Naylor1, Carrie L Griffiths.   

Abstract

Glucocorticoid-induced myopathy is a common side effect of chronic glucocorticoid therapy. Several mechanisms are currently being examined as ways in which glucocorticoid-induced myopathy occurs. These include apoptotic signaling through mitochondrial-mediated and Fas-mediated apoptosis, the role of the proteosome, the suppression of the IGF-1 signaling, and the role of ceramide in glucocorticoid-induced apoptosis and myopathy. It is difficult to differentiate which mechanism may be the initiating event responsible for the induction of apoptosis; however, all of the mechanisms play a vital role in glucocorticoid-induced myopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520160     DOI: 10.1016/j.jsbmb.2009.05.014

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  18 in total

Review 1.  Drug-related myopathies of which the clinician should be aware.

Authors:  Ritu Valiyil; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

2.  Muscle transcriptome response to ACTH administration in a free-ranging marine mammal.

Authors:  Jane I Khudyakov; Cory D Champagne; Likit Preeyanon; Rudy M Ortiz; Daniel E Crocker
Journal:  Physiol Genomics       Date:  2015-06-02       Impact factor: 3.107

Review 3.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

Review 4.  Update on toxic myopathies.

Authors:  F L Mastaglia; M Needham
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 5.  Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Authors:  Nils D Arvold; Terri S Armstrong; Katherine E Warren; Susan M Chang; Lisa M DeAngelis; Jaishri Blakeley; Marc C Chamberlain; Erin Dunbar; Herbert H Loong; David R Macdonald; David A Reardon; Michael A Vogelbaum; Ying Yuan; Michael Weller; Martin van den Bent; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

Review 6.  Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Raolat M Abdulai; Tina Jellesmark Jensen; Naimish R Patel; Michael I Polkey; Paul Jansson; Bartolomé R Celli; Stephen I Rennard
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

Review 7.  The interplay between bioactive sphingolipids and steroid hormones.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Steroids       Date:  2010-02-04       Impact factor: 2.668

8.  Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Nina M Semjonous; Mark Sherlock; Pancharatnam Jeyasuria; Keith L Parker; Elizabeth A Walker; Paul M Stewart; Gareth G Lavery
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

9.  The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice.

Authors:  Joo Wan Kim; Sae-Kwang Ku; Min Ho Han; Ki Young Kim; Sung Goo Kim; Gi-Young Kim; Hye Jin Hwang; Byung Woo Kim; Cheol Min Kim; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2015-05-04       Impact factor: 4.101

10.  Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.

Authors:  Amanda L Gruver-Yates; John A Cidlowski
Journal:  Cells       Date:  2013-03-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.